Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation

Overview of attention for article published in Frontiers in Pharmacology, June 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 17 Mendeley

So far, Altmetric has seen 1 X post from an account with 5,883 followers.

New Research: Salvage Therapy With Low-Dose Ruxolitinib Leads to a Significant Improvement in Bronchiolitis Obliterans Syndrome in Patients With cGVHD After Allogeneic Hematopoietic Stem Cell Transplantation https://t.co/C66GGhJPJI #pharmacology

28 Jun 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.